Analysis of the deterioration rates of liver function in cirrhosis, based on galactose elimination capacity

Liver

Volumn 10, Issue 2, 1990, Pages 65-71

  Marchesini, G ^a   Fabbri, A ^a   Bugianesi, Elisabetta ^a   Bianchi, G P ^a   Marchi, Elisabetta ^a   Zoli, M ^a   Pisi, E ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

alcohol consumption; cirrhosis; galactose elimination capacity; liver function; prognosis

Indexed keywords

GALACTOSE;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE;

ADULT; FEMALE; GALACTOSE; HUMAN; LIFE EXPECTANCY; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0025282039     PISSN: 01069543     EISSN: 16000676     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1990.tb00438.x     Document Type: Article

References (20)

1. Functional evaluation of the hepatocyte
2. The aminopyrine demethylation breath test and the serum bile acid levels: nominated but not yet elected to join the common liver tests
3. Quantitative assessment of deranged hepatic function: a missed opportunity?
4. The quantitative liver function as measured by the galactose elimination capacity
5. Determination of the hepatic elimination capacity (Lm) of galactose by single injection
6. A 20‐years prospective study of cirrhosis
7. Quantity and quality of survival after portosystemic shunts
8. Factors influencing survival after therapeutic shunts
9. Fifteen years' experience with portosystemic venous shunting operations
10. A controlled study of the prophylactic portocaval shunt: a final report
11. Cirrhotic portal hypertension: morbidity of continued alcoholism
12. Effect of alcohol abstinence on survival in cirrhotic portal hypertension
13. Duration of survival in patients with Laennec's cirrhosis
14. Sex, ascites and alcoholism in survival of patients with cirrhosis. Effect of prednisone
15. Splanchnic galactose uptake in patients with cirrhosis following single injection
16. Splanchnic galactose uptake in patients with cirrhosis during continuous infusion
17. Galactose clearance measurements and liver blood flow
18. Changes of laboratory variables with time: prognostic and therapeutic significance